305 results

• Five Valsartan Lawsuits Selected for Second Round of Bellwether Trials

  January 6, 2025

  Irvin Jackson

  A Special Master has ordered that five more Valsartan lawsuits be prepared for a second round of potential bellwether trials, to further test claims that the recalled blood pressure drugs caused users to develop cancer.

• Hypertension During Pregnancy Linked to Later Development of Neurological Disorders in Mothers: Study

  January 3, 2025

  Michael Adams

  Women diagnosed with hypertensive disorders during pregnancy have a greater risk of developing adult-onset neurological conditions years after they have given birth.

• Study Links Side Effects of Tylenol, Acetaminophen to Increased Ulcer Risks

  December 9, 2024

  Irvin Jackson

  Although Tylenol and other acetaminophen pain medications have been widely believed to be safe, side effects have been linked to a number of concerns in recent years, including reports of liver damage, life-threatening skin reactions and developmental problems for children.

• Valsartan Bellwether Lawsuit Over Cancer Caused by Recalled Blood Pressure Drug Set for Trial September 8, 2025

  December 4, 2024

  Irvin Jackson

  The first Valsartan bellwether trial will begin on September 8, 2025, involving allegations that the generic hypertension drug contained toxic chemicals that resulted in a liver cancer diagnosis.

• Infant PFAS Exposure Linked to Cholesterol and Weight Problems, Study Warns

  November 13, 2024

  Irvin Jackson

  A new study suggests that PFAS exposure in utero could increase the risk of hypertension, diabetes and other metabolic disorders in newborns.

• Side Effects of Beta Blockers May Increase Risk of Stroke After Surgery: Study

  November 11, 2024

  Martha Garcia

  Study finds that beta blockers may increase the risk of stroke after surgery, leading to calls for further research to determine how the medications can be safely used before medical procedures.

• Valsartan Liver Cancer Lawsuit Selected for First Jury Trial in MDL

  October 28, 2024

  Irvin Jackson

  The first bellwether trial in the federal Valsartan MDL will involve claims brought by an Alabama man diagnosed with liver cancer, which is the injury most commonly reported among former users of the recalled blood pressure drug.

• Valsartan Cancer Lawsuits To Be Set for First Bellwether Trial, Instead of Third-Party Payor Claim

  October 22, 2024

  Irvin Jackson

  Following the postponement of a third party payor trial previously set to begin this month, the judge presiding over all valsartan lawsuits will hold a conference today with lawyers to discuss the selection of a cancer claim that will now be the first to go before a jury.

• Surrogate Mothers Face Increased Risks of Hypertension, Bleeding and Preterm Birth: Study

  October 4, 2024

  Martha Garcia

  A new study suggests that surrogate mothers may face a higher risk of pregnancy and birth related complications than women in other types of fertility treatment, but researchers do not yet understand why.

• Sanctions Imposed in Valsartan Recall Lawsuits Over Drug Maker’s Discovery Violations

  July 25, 2024

  Irvin Jackson

  A Chinese generic valsartan manufacturer has been fined more than 300,000 for failing to adhere to discovery requirements and make its CEO available for depositions.